BIOCOM for BIOCOM
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Energy/Nuclear ENG
Supported mandatory funding for the Energy Title in the Farm Bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Taxation/Internal Revenue Code TAX
Advocated for the suspension of the medical device tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Health Issues HCR
Supported the reauthorization of PAHPA Expressed concerns with step therapy policy, reference pricing, changes to Medicare Part B, and changes to the Part D protected classes Discussed how the life science community can help address the opioid crisis Advocated for reforms of the 340B drug program
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Budget/Appropriations BUD
Advocated for increased funding for NIH and FDA in FY2019 appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Copyright/Patent/Trademark CPT
Lobbied in opposition to "compulsory licenses" policies Advocated for reforms of IPR proceedings at the PTAB, including support of the STRONGER Patents Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.